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Abstract: In this study, we sought to label mouse bone marrow-derived endothelial progenitor 
cells (EPCs) with Resovist® in vitro and to image them using 7.0 Tesla (T) magnetic resonance 
imaging (MRI). Mouse bone marrow-derived EPCs were cultured in endothelial basal medium 
with endothelial growth supplement. They were then characterized by immunocytochemistry, flow 
cytometry, and fluorescence quantitative polymerase chain reaction. Their functions were evalu-
ated by measuring their uptake of 1,1-dioctadecyl-3,3,3,3-tetramethylindocarbocyanine-labeled 
acetylated low-density lipoprotein (Dil-Ac-LDL), binding of fluorine isothiocyanate (FITC)-
labeled Ulex europaeus agglutinin (UEA), and formation of capillary-like networks. EPCs were 
labeled with superparamagnetic iron oxide (SPIO) and their proliferation was then assessed in a 
water-soluble tetrazolium (WST-8)-based cell proliferation assay. Spin echo sequence (multislice, 
multiecho [MSME]) and gradient echo sequence (2D-FLASH) were used to detect differences 
in the numbers of labeled cells by 7.0 T MRI. The results showed that the cultured cells were of 
“cobblestone”-like shape and positive for CD133, CD34, CD31, von Willebrand factor, kinase 
domain receptor, and CD45, but negative for F4/80. They could take up Dil-Ac-LDL, bind FITC-
UEA, and form capillary-like networks on Matrigel in vitro. Prussian-blue staining demonstrated 
that the cells were efficiently labeled with SPIO. The single-cell T2* effect was more obvious in 
the 2D-FLASH sequence than in the MSME sequence. Further, there were almost no adverse 
effects on cell vitality and proliferation. In conclusion, mouse bone marrow-derived EPCs can 
be efficiently labeled with SPIO and imaged with 7.0-T MRI. They may thus be traced by MRI 
following transplantation for blood vessel disorders and cancer treatment.
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Introduction
Endothelial progenitor cells (EPCs) are derived from bone marrow and were first 
isolated and purified from human peripheral blood by Asahara et al.1 EPCs can 
proliferate independently and differentiate into mature endothelial cells (ECs).2 The 
ability of EPCs to promote revascularization of injured and ischemic tissues means 
they may be useful in cellular therapies and provide a new approach to therapeutic 
angiogenesis. EPCs are also promising in cancer therapy as a result of their capacity 
to invade, migrate within, and incorporate into tumor structures.3 Furthermore, EPCs 
can migrate to ischemic regions of tumor tissue and incorporate into newly formed 
tumor blood vessels.4,5 Cellular therapies targeting cancer growth are currently being 
tested in preclinical models.6–8 Using gene transfer techniques, the therapeutic potential 
of EPCs may be enhanced. These features make EPCs attractive cellular vehicles for 
systemic tumor gene therapy.3International Journal of Nanomedicine 2011:6 submit your manuscript | www.dovepress.com
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It is essential to trace transplanted stem cells during 
their migration and differentiation. Of the methods used 
to track labeled cells, magnetic resonance imaging (MRI) 
has several advantages, such as high spatial and temporal 
resolution and good tissue contrast. It is also noninvasive 
and can be used to track cellular events in vivo in real time.4 
MR imaging of stem cells is also an emerging strategy for 
monitoring cell engraftment.5 The superparamagnetic iron 
oxides (SPIOs) are a class of MR contrast agents that gener-
ate strong T2-negative contrast in MRI and decrease signal 
intensity. Resovist® is a kind of SPIO. It acts by reducing the 
transverse relaxation time (T2) in T2-weighted MRI scans; 
thus, labeled cells appear as areas of reduced signal intensity. 
MRI tracking of cells labeled with SPIO has become a 
valuable technique.9,10 In our laboratory, we previously 
visualized SPIO-labeled EPCs from the peripheral blood of 
New Zealand rabbits.11,12
To our knowledge, no reported study has tested Reso-
vist labeling of mouse bone marrow-derived EPCs and 
their subsequent imaging by 7.0 Tesla (T) MR. Here, we 
investigated the characteristics of EPCs in vitro and the 
efficiency of their labeling with Resovist. In this study, 
mouse bone marrow-derived EPCs were isolated and 
cultured. Their identity was confirmed by measuring their 
expression of cellular surface markers and assessing their 
function. We subsequently labeled cells with SPIO and 
imaged them using 7.0 T MR, which has a high signal-to-
noise ratio (SNR).
Materials and methods
Isolation of bone marrow-derived EPCs
Mononuclear cells were isolated from the bone marrow of 
C57/BL6 mice. Mice were heparinized before harvesting. 
Briefly, under aseptic conditions, mouse bone marrow mono-
nuclear cells (BMPCs) were isolated from the femora and tibia 
by flushing the marrow cavities with RPMI 1640 medium 
(Clonetics, Sunnyvale, CA). After washing through cen-
trifugation in Histopaque 1077 (400 g, 25 minutes; Sigma-
Aldrich, St. Louis, MO), the cells were resuspended in 
culture medium supplemented with endothelial basal medium 
(EBM-2; Clonetics) and EGM-2 SingleQuots endothelial 
growth supplement (Clonetics) and plated in 6-well culture 
plates coated with fibronectin (Gibco, Carlsbad, CA). The 
cells were maintained in a humidified 5% CO2 atmosphere 
at 37°C. The growth medium was replaced every other day. 
Nonadherent cells were removed after 48 hours and every 
second day thereafter.
Flow cytometric analysis
Proportions of cells positive for CD133, CD31, CD34 
and KDR, and CD45 and F4/80 were determined by flow 
cytometry. Cells were washed with phosphate-buffered 
saline (PBS) and then incubated with fluorine isothio-
cyanate (FITC)-CD34, PE-CD133, FITC-CD31, PE-KDR, 
PE-CD45 and FITC-F4/80 primary antibodies (Abcam, 
Cambridge, MA) for 15–20 min. After washing with 
PBS, cells were then incubated with secondary antibodies 
(KPL, Gaithersburg, MD) for 30 minutes. Isotype-matched 
antibodies were used as controls. All steps were performed 
at 4°C. Samples were analyzed using a FACScan instrument 
(FACSCalibur, FACSCanto; BD Biosciences, Franklin Lakes, 
NJ) and CellQuest software (BD Biosciences).
Indirect immunofluorescence staining
Cells were grown on fibronectin-coated glass coverslips and 
analyzed for the expression of the cellular markers CD31, 
kinase domain receptor (KDR), and von   Willebrand factor 
(vWF). Briefly, cells mounted on cover-slips were fixed 
through incubation with cold acetone for 10 minutes, washed 
with PBS three times and then incubated with primary anti-
bodies for 60 minutes at 37°C. FITC-labeled secondary anti-
bodies were then added for 30 minutes. PBS without primary 
antibodies served as negative   controls and cell nuclei were 
stained with 4′,6-diamidino-2-phenylindole (DAPI) at the 
same time. Cells were examined with an inverted Imaginer 
A1 fluorescence microscope (Carl Zeiss, Jena, Germany).
Phagocytotic activity assay
Fluorescent chemical detection of EPCs was performed 
on cells that were adherent after 7 days of culture. Direct 
fluorescent staining was used to detect the dual binding of 
FITC-labeled Ulex europaeus agglutinin (UEA) and 1,1-
dioctadecyl-3,3,3,3-tetramethylindocarbocyanine-labeled 
acetylated low-density lipoprotein (Dil-Ac-LDL). Cells were 
first incubated with Dil-ac-LDL (5 µg/mL) at 37°C for 2 hours 
and then fixed through incubation with 4% paraformaldehyde 
for 20 minutes. They were   subsequently incubated with UEA 
(10 µg/mL) at 37°C for 1 hour. After washing with PBS, the 
cells were visualized and photographed using a fluorescence 
microscope and counted at ×200 magnification. Double-
positive cells were considered to be differentiating EPCs.
Tube formation assay in Matrigel
Matrigel (BD Biosciences) was added to the wells of a 
96-well plate (45 µL/well) and allowed to polymerize for International Journal of Nanomedicine 2011:6 submit your manuscript | www.dovepress.com
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30 minutes at 37°C. Cells (1 × 104/well in 100 µL of EGM-2) 
were seeded on top of the Matrigel.13 After incubation for 
6 hours, the formation of tube-like structures was evaluated 
using a light microscope. Human umbilical vein endothelial 
cells (HUVECs) were used as an endothelial control line.
Fluorescence quantitative polymerase 
chain reaction (PCr)
Freshly cultured EPCs were harvested and total RNA was 
isolated using Trizol (Invitrogen, Carlsbad, CA) according 
to the manufacturer’s instructions. Five micrograms of total 
RNA was reverse-transcribed to cDNA. Quantitative real-
time PCR assays were run in triplicates under the following 
conditions: 95°C for 2 minutes; (95°C, 10 seconds; 60°C,   
30 seconds) × 40 cycles. Primer sequences are shown in 
Table 1. Data are expressed as ∆∆ct = average value of ct 
(cycle threshold) (object gene) – average value of ct (house-
keeping gene).
Labeling of ePCs with nano iron particles
Resovist (SHU555 A; Schering, Berlin, Germany) has par-
ticles about 56 nm in size and the iron content is 28 mg/ml. 
Before labeling, Resovist was diluted with endothelial cell 
growth medium-2 (EGM-2). EPCs were incubated with 
labeling medium containing 28 µg/mL iron for 24 hours.14 
They were then washed three times with PBS and harvested 
using 0.25% trypsin. A trypan blue exclusion assay was 
then performed to measure cell viability and to assess the 
cytotoxicity of iron labeling to EPCs.
Determination of labeling efficiency
After incubation with SPIO, cells were washed three times 
with PBS to remove excess iron oxides and then subjected 
to Prussian blue (PB) staining. Cells were fixed through 
incubation with 4% paraformaldehyde for 30 minutes, and 
then incubated for 30 minutes with 10% potassium ferrocya-
nide in 10% hydrochloric acid, washed, and counterstained 
with nuclear fast red. Cells containing intracytoplasmic 
blue granules were considered to be PB-positive. Labeling 
efficiency was determined by manually counting PB-stained 
and nonstained cells using a microscope. The percentages 
of positive cells were determined from the counts from an 
average of 5–10 high-power fields.
effect of iron labeling on cell proliferation
A water-soluble tetrazolium (WST-8)-based colorimetric 
proliferation assay (Cell Counting Kit-8; KeyGen Biotech, 
Nanging, China) was performed using SPIO-labeled and 
unlabeled EPCs according to the manufacturer’s instruc-
tions.15 Cells were trypsinized and resuspended in 500 µL 
of medium. Cells (5 × 103/well) were plated to fibronectin-
coated 96-well plates and SPIO was added to certain wells 
for 24 hours. After washing with PBS, 10 µL of CCK-8 was 
added to each well. After incubation for a further 3 hours at 
37°C, OD values at 450 nm were measured with an enzyme-
linked immunosorbent detector (TECAN, Männedorf, 
Switzerland). This experiment was continued for 10 days 
and growth curves were constructed for iron-labeled and 
unlabeled cells.
Table 1 Primer sequences of PCr
Gene Primer Fragment length (bp)
MUS-CD31-F (bp1653) 5′-TAGCAAGAAGCAGGAAGGACAG-3′ 141
MUS-CD31-R (bp1794C) 5′-AATGACAACCACCGCAATGA-3′
MUS-CD31-P 5′-FAM-ACAGCCTCCAACAGAGCCAGCAGT-TAMRA-3′
MUS-vWF-F (bp3906) 5′-GAATTGTCACTGTGATGGTGTGAA-3′ 111
MUS-vWF-R (bp4017C) 5′-CTCAACATATGGGGTGGTAGAGC-3′
MUS-vWF-P 5′-FAM-ACGTGTGAAGCCTGCCAAGAGCC-TAMRA-3′
MUS-KDR-F (bp451) 5′-CCAATGCTCAGCGTGATTCT-3′ 93
MUS-KDR-R (bp544C) 5′-ACCCTGGGAATGGTGAGTGT-3′
MUS-KDR-P 5′-FAM-ACCGCCGCATTCAGTCACCAATA-TAMRA-3′
MUS-ACTB-F (bp573) 5′-TCTACGAGGGCTATGCTCTCC-3′ 146
MUS-ACTB-R (bp719C) 5′-CTTTGATGTCACGCACGATTT-3′
MUS-ACTB-P 5′-FAM-CATCCTGCGTCTGGACCTGGCTG-TAMRA-3′
Abbreviations: PCR, polymerase chain reaction; vWF, von Willebrand factor.International Journal of Nanomedicine 2011:6 submit your manuscript | www.dovepress.com
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Magnetic resonance imaging
Labeled cells were washed in PBS, trypsinized and 
fixed through incubation with 4% paraformaldehyde for 
30 minutes at 4°C. Cells were then diluted in 0.3% agarose 
to 1 × 106, 1 × 105 and 1 × 104 cells/mL. MR imaging 
(7.0 T; PharmaScan, Bruker, Germany) was performed 
using a 23-mm mouse head circular volume coil. The MR 
sequences were a fast low-angle shot gradient echo sequence 
(2D-FLASH) and a multislice, multiecho (MSME) sequence. 
Imaging parameters for 2D-FLASH were as follows: rep-
etition time (TR) = 471.1 ms, echo time (TE) = 7.5 ms, 
field of view = 3.0 × 3.0 cm2, matrix = 384 × 384, slice 
thickness = 0.28 mm, spacing layer = 0.43 mm, and flip 
angle = 13°. The total scan time was 22 minutes, 36 seconds. 
The parameters for the MSME sequence were: TR = 2000 ms, 
TE = 31.7 ms, FOV = 3.85 × 3.0 cm2, matrix = 512 × 384, 
slice thickness = 0.28 mm, spacing layer = 0.43 mm, flip 
angle = 180°, and scale time = 9 minutes, 36 seconds.
statistical analyses
All values are expressed as mean ± standard deviation. 
Student’s t-test was used to identify significant differences 
between groups. Values of P , 0.05 were considered sta-
tistically significant. All tests were performed using SPSS 
software (version 13.0; SPSS Inc., Chicago, IL).
The contrast analysis of the 2D-FLASH sequence and the 
MSME sequence involved choosing 10 cells of the correspond-
ing deck in the two sequences, setting the threshold value of the 
pixel (value . average) with Image J software and counting 
the number of pixels affected by each cell.   Student’s t-test was 
used with SPSS. Significance was assumed at P , 0.05.
Results
Isolation and characterization of ePCs
As shown in Figure 1, bone marrow-derived mononuclear 
cells (MNCs) were cultured on fibronectin-coated plates 
in the presence of the endothelial cell growth supplement 
EGM-2. Cells changed from a globe-like shape to being 
thin and flat at day 4 (left, ×100), and they acquired a round, 
fusiform pebble-like shape at days 7–10 (right, ×100).
Results of flow cytometric analyses of bone marrow-derived 
cells, showing the cells expressed EPCs’ characteristic mark-
ers CD133, CD34, and KDR. These cells also expressed 
EC-specific markers CD31 and the pan-leukocyte marker 
CD45, but did not express F4/80 (Figure 2).
Indirect immunofluorescent staining was performed to 
further examine the expression of cellular markers in the 
isolated cells. The results show that the cells expressed CD31, 
vWF, and KDR (×200; Figures 3A–D). After 7 days of culture, 
FITC-UEA and Dil-Ac-LDL double-positive cells were 
observed by fluorescent microscopy (×200; Figures 3E–H).
We used a Matrigel model to examine whether our 
cultured cells could be induced to form capillary-like 
structures. The results showed that the EPCs can form a 
capillary-like structure as the mature ECs in human umbilical 
vein (×100; Figure 4).
Fluorescence quantitative PCR was used to analyze 
marker expression at the mRNA level. Results showed that 
vWF, KDR, and CD31 mRNA were detectable in EPCs 
(Figure 5).
Labeling efficiency
After staining with Prussian blue, iron-labeled cells were 
found to accumulate iron in the cytosol (Figure 6B) after they 
were labeled with iron particles (Figure 6A). This indicates that 
the cells were labeled with iron particles and could be tracked 
by MRI. As shown in Figure 5C, the average percentage 
viabilities of the labeled and unlabeled cells were 87.6% 
and 92.2%, respectively. There was no significant difference 
between the groups (P . 0.05). The efficiency of SPIO label-
ing was nearly 100%, as determined by the manual counting 
of PB-stained and unstained cells using a microscope.
Proliferation potential
As shown in Figure 7, after 9 days of culture, a cell prolifera-
tion assay revealed that there was no statistically significant 
difference in the growth curves for labeled and unlabeled 
EPCs between days 2 and 9 (P . 0.05).
MrI results
MRI showed areas of signal deletion in the MSME sequence 
(Figures 8A, C) were smaller than in the 2D-FLASH 
sequence (Figures 8B, D) and that the signal intensity was 
higher in the MSME sequence. This indicated that the 
AB
Figure 1 Morphological changes in mouse bone marrow-derived MNCs. A) Cells 
changed from globe-like shape to being thin and flat, and then round and fusiform 
at day 4 (magnification ×100). B) At days 7–10, the cells exhibited a typical long 
fusiform or “cobblestone” morphology (magnification ×100).
Abbreviation: MNCs, mononuclear cells.International Journal of Nanomedicine 2011:6 submit your manuscript | www.dovepress.com
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T2* effect was stronger in 2D-FLASH than in MSME, and 
that the former was thus more sensitive for detecting single 
cells. The average numbers of voxels affected by the cells 
were 20.2 ± 3.2 in the MSME sequence and 28.9 ± 4.0 in 
the 2D-FLASH sequence. The difference between the two 
groups was significant (P , 0.05).
Discussion
EPCs are progenitor cells that can proliferate and differenti-
ate into mature ECs, maintaining normal adult endothelial 
function through re-endothelialization and angiogenesis.1,16 
The results of many previous studies have confirmed that 
EPCs preferentially target tumors and contribute to tumor 
vasculature.17,18 These observations suggesting that EPCs 
have a predilection for tumor vasculature led to the hypoth-
esis that EPCs could be armed with therapeutic payloads 
and used as delivery vehicles for tumor gene and/or cell 
therapy.19,20 Although numbers of EPCs in the bone marrow 
and circulation are very low, they may be readily expanded 
in vitro. Ex vivo-expanded EPCs have been widely used in 
experimental studies and may feasibly be used in clinical cell 
therapies.21 The main purpose of this study was to expand 
EPCs in vitro, to label them with SPIO, and to image them 
using MRI with a view to possibly using them in tumor gene 
therapies in the future.
When incubated in vitro with appropriate medium and 
specific growth factors, such as vascular endothelial growth 
factor, human fibroblast growth factor-B, and human epider-
mal growth factor, EPCs have a high proliferation potential 
and produce colonies of cells expressing EC markers, such 
as CD34, CD133, and KDR. Key characteristics of EPCs 
include a “cobblestone” morphology and expression of 
endothelial marker proteins, as well as the ability to form 
tube-like structures in vitro, as described previously.22 The 
molecular markers for EPCs are controversial, but the most 
commonly used ones are CD34, CD133, and KDR.23 CD34 
and KDR were used by Asahara et al1 as cell markers to 
isolate cells from peripheral blood before inducing them to 
form mature ECs. From then on, CD34 and KDR are the 
most two common markers for isolating EPCs. CD133 was 
found to discriminate EPCs from mature ECs. So CD34, 
KDR and CD133 were thought to be the specific molecular 
markers for isolating EPCs from bone marrow, peripheral 
blood. CD45 was the pan-leukocyte marker and research24 
found that the CD45dim fraction contains the prognostic rel-
evant EPC populations. In the present study, isolated mouse 
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Figure 2 In FACs analyses, ePCs were positive for CD133 (B, 0.5%), CD34 (B, 4.1%), KDr (C, 3.9%), the mature EC-specific marker CD31 (C, 5.4%), the pan-leukocyte 
marker CD45 (D, 2.6%) and negative for F4/80 (D). Isotype controls were used in the FACs analyses (A).
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Figure 3 Mouse bone marrow-derived MNCs differentiate into cells with endothelial progenitor cell-like characteristics after expansion in vitro.
Notes: Immunocytochemical analysis of cells cultured for 7 days revealed the expression of the mouse endothelial cell markers CD31 (A), vWF (B), and KDr (C). All 
antibodies were directly labeled with FITC. Cell nuclei were stained with DAPI. Control cells were incubated with PBS in place of primary antibody (D). These exhibited 
uptake of acetylated LDL (F) and bound FITC-labeled lectin (E) after 7 days in culture. Cell nuclei were stained with DAPI (G). H) Overlap of these three images. 
Magnification: ×200.
Abbreviations: DAPI, 4′,6-diamidino-2-phenylindole; FITC, fluorescein isothiocyanate; KDR, kinase domain receptor; LDL, low-density lipoprotein; MNCs, mononuclear 
cells; PBS, phosphate-buffered saline; vWF, von Willebrand factor.International Journal of Nanomedicine 2011:6 submit your manuscript | www.dovepress.com
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To date, two iron oxide-based agents have been developed 
and approved for clinical MRI: ferumoxides (Endorem; 
distributed in the USA as Feridex) with a particle size of 
50–180 nm and ferucarbotran (SHU555 A; Resovist) with a 
particle size of approximately 60 nm. Resovist is used in both 
dynamic and delayed imaging. Additionally, the safety profile 
for Resovist appears more favorable. Studies have shown that 
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Figure  6  Nano  iron  particle  labeling  of  endothelial  progenitor  cells.  A)  The 
cytochylema in Resovist-labeled cells contained brown-colored granules. B) Prussian 
blue staining for iron showed the cytosolic deposition of blue crystals. C) A trypan 
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iron-labeled cells.
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Figure  4  Comparison  of  the  ability  to  form  capillary-like  structure  between 
hUVeCs and ePCs. A) Capillary-like structure formation in HUVECs as positive 
control  (magnification  ×100).  B)  Bone  marrow-derived  EPCs  form  the  same 
capillary-like clusters (magnification ×100).
Abbreviations: ePCs, endothelial progenitor cells; hUVeCs, human umbilical vein 
endothelial cells.
bone marrow-derived multinuclear cells were cultured 
in endothelial basal medium with an endothelial growth 
supplement. The medium was replaced every other day to 
ensure continuous cytokine stimulation. Within 3–4 days, 
colonies of cells with various morphologies formed. After 
approximately 7 days of growth, the cells exhibited a typical 
endothelial cobblestone morphology and expressed CD31, 
vWF, CD34, CD45, and KDR, but did not express F4/80 
(widely recognized as a marker for mouse macrophages). 
At the same time, Dil-ac-LDL/FITC-UEA double-positive 
cells (ie, differentiated EPCs) were identified and counted 
using a fluorescence microscope. Also, we found that these 
amplified cells could form tube-like structures on Matrigel 
in vitro. Collectively, these observations indicated that mice 
bone marrow-derived MNCs can transdifferentiate into cells 
with an endothelial phenotype and endothelial functions after 
stimulation with endothelial growth factors in vitro.
In recent years, some studies have found that monocytes 
can mimic EPCs by their expression of surface markers 
and the ability to form cord- and tubular-like structures 
in vitro.25–27 These findings will make monocytes phenotypi-
cally indistinguishable from EPCs and may offer a new road 
for angiogenic therapies.
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Figure 5 Quantitative PCR analysis of vWF, VEGFR-2, CD31 mRNA levels from 
mouse bone-marrow derived EPCs.
Abbreviations: ePCs, endothelial progenitor cells; VEGFR-2, vascular endothelial 
growth factor-2; vWF, von Willebrand factor.International Journal of Nanomedicine 2011:6 submit your manuscript | www.dovepress.com
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labeling multipotent adult progenitor cells (MAPCs) and 
neural precursor cells (NPCs) with ferucarbotran (Resovist, 
Schering AG) at a concentration of 25 µg Fe/mL for 24 hours 
was 100% efficient and did not impair cell survival or sphere-
forming ability or compromise multipotency.14,28 In the pres-
ent study, we have, for the first time, labeled mouse bone 
marrow-derived EPCs with Resovist, and have described a 
simple in vitro protocol for labeling EPCs of mouse origin 
that does not impair proliferative ability. We showed, through 
Prussian blue staining, that labeling of cells with Resovist 
under the same conditions was almost 100% effective. 
Growth curve analysis further showed that SPIO labeling 
had no effect on cell vitality or proliferation.
MRI has been used for noninvasive imaging of low num-
bers of SPIO-labeled cells following transplantation.28 The 
gradient magnetic fields produced in small areas by single 
labeled cells leads to T2* effect increases. Thus, MRI could 
track labeled cells more easily because the areas of signal 
deletion (200 µm) were bigger than those of the unlabeled 
cells (20 µm).29 We have demonstrated that the punctiform 
signal deletion was caused by labeled cells.30 The 2D-FLASH 
sequence was more sensitive with the uneven magnetic 
field than the MSME sequence and thus better for detecting 
individual labeled cells.
To summarize, in this study we successfully cultured, 
labeled, and MR imaged EPCs. Additionally, we showed that 
SPIO labeling had almost no adverse effect on cell activity 
or proliferation. Magnetic labeling of cells with SPIO may 
be useful for monitoring the temporal and spatial migration 
of EPCs into tissues and may facilitate the development of 
cell-based gene therapies for carcinomas.
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